Pune-Based Serum Institute Of India Begins Work On Monkeypox Vaccine

Serum Institute of India (SII) on Tuesday said it is currently working to develop a vaccine for Monkeypox, with positive outcomes expected in a year's time.

The World Health Organisation (WHO) on August 14 declared the Mpox outbreak a public health emergency of international concern. The move came after a sudden increase in cases was recorded in parts of Africa.

In India, around 30 Mpox cases have been detected since 2022. The most recent case in the country was reported in March 2024.

"In view of the global health emergency declared due to Mpox outbreak, SII is currently working on developing a vaccine for this disease to cater to millions of lives that might be at risk," SII CEO Adar Poonawalla said in a statement.

Hopefully, with the ongoing progress, the Pune-based vaccine major will have more updates and positive news to share within a year's time, he added.

The Union Health Ministry has issued advisories highlighting that scrutiny at airports and seaports, especially at international entry points will increase.

The government has declared three hospitals -- Ram Manohar Lohia Hospital, Safdarjung Hospital, and Lady Hardinge Medical College -- as nodal centres for the isolation, management and treatment of patients.